Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

Nadine L. de Boer, Job P. van Kooten, Jacobus W. A. Burger, Cornelis Verhoef, Joachim G.J.V. Aerts, Eva V. E. Madsen

BMJ Open

Abstract

References